TIS 0.00% 0.0¢ tissue therapies limited

Agree advisor. While the change in device classification is a...

  1. 492 Posts.
    Agree advisor. While the change in device classification is a short term impediment, it may debottleneck and expedite the the roll out of VG across the EU after a short 7 month period. Appreciate some holders may be perturbed right now, but by TIS management commencing preparatory work for a possible referral in August, it demonstrates prudent contingency planning.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.